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Abstract
 Background—The World Health Organization recently released recommendations stating that 
red blood cell (RBC) folate concentrations should be above 400 ng/L (906 nmol/L) for optimal 
prevention of folate-sensitive neural tube defects (NTDs). The objective of this study was to 
determine the distribution of folate insufficiency (FI) (<906 nmol/L) and potential risk of NTDs 
based on RBC folate concentrations among nonpregnant women of child-bearing age in 
Guatemala.
 Methods—A national and regional multistage cluster probability survey was completed during 
2009 to 2010 among Guatemalan women of child-bearing age 15 to 49 years of age. Demographic 
and health information and blood samples for RBC folate analyses were collected from 1473 
women. Prevalence rate ratios of FI and predicted NTD prevalence were estimated based on RBC 
folate concentrations comparing subpopulations of interest.
 Results—National FI prevalence was 47.2% [95% confidence interval, 43.3–51.1] and showed 
wide variation by region (18–81%). In all regions, FI prevalence was higher among indigenous 
(27–89%) than among nonindigenous populations (16–44%). National NTD risk based on RBC 
folate concentrations was estimated to be 14 per 10,000 live births (95% uncertainty interval, 
11.1–18.6) and showed wide regional variation (from 11 NTDS in the Metropolitan region to 26 
NTDs per 10,000 live births in the Norte region).
 Conclusion—FI remains a common problem in populations with limited access to fortified 
products, specifically rural, low income, and indigenous populations. However, among 
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subpopulations that are most likely to have fortified food, the prevalence of FI is similar to 
countries with well-established fortification programs.
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 Introduction
It is estimated that each year more than 300,000 newborns worldwide are born with neural 
tube defects (NTDs) (Christianson et al., 2006). These devastating birth defects (including 
anencephaly and spina bifida) happen in the early weeks of pregnancy, often before a 
woman knows she is pregnant. Many of these NTDs can be prevented if women have 
adequate folic acid intake before conception (MRC Vitamin Study Group, 1991; Czeizel and 
Dudas, 1992). To promote folic acid intake, in 1992 the United States Public Health Service 
recommended that women of child bearing age (WCBA) who could become pregnant should 
consume 400 μg of folic acid daily (Centers for Disease Control and Prevention, 1992). 
Several countries (e.g., Canada, Chile, Costa Rica, United States) increased folic acid intake 
through mandatory folic acid fortification, and all observed reductions in the prevalence of 
NTDs, ranging from 31 to 78% (De Wals et al., 2008; Hertrampf and Cortes, 2008; Arguello 
and Umaña, 2011; Rosenthal et al., 2013; Williams et al., 2015). These and other data 
suggest increasing folic acid intake can reduce NTD rates to as low as 5 to 6 per 10,000 
births (Berry et al., 1999; Arguello and Umaña, 2011; Rosenthal et al., 2013; Williams et al., 
2015; Cordero et al., 2015). However, achieving such reductions depends on the 
effectiveness of interventions for increasing folic acid intake among WCBA before 
pregnancy.
To help monitor the effectiveness of folic acid interventions, the World Health Organization 
(WHO) has recently released a new guideline that establishes a threshold for optimal red 
blood cell (RBC) folate concentration for neural tube defect (NTD) prevention (>400 ng/L 
or 906 nmol/L) (WHO, 2015). This threshold can be used to help public health officials 
determine if their overall populations or subpopulations are at risk for folate-sensitive (and 
thus preventable) NTDs.
In this study, the objective was to apply the new WHO guideline for the first time in a 
developing country, to determine if the current RBC folate concentrations are consistent with 
optimal NTD prevention and to identify groups of women who continue to be at increased 
risk of a folate-sensitive NTD-affected pregnancy. To do so, we used the Guatemala 
Encuesta Nacional de Micronutrientes (ENMICRON) data collected in 2009 to 2010. These 
data were of special interest because in 2003 Guatemala increased the amount of folic acid 
in fortified wheat flour from 1.08 to 1.80 mg/kg (David, 2004) with the goal of providing 
adequate intake of folate to WCBA. As part of the study, we assessed the prevalence of 
folate insufficiency based on RBC folate concentrations at national and regional levels, and 
by population sociodemographic characteristics. Then we used the RBC folate 
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concentrations to model the estimated risk of NTDs among nonpregnant women ages 15 to 
49 years.
 Participants and Methods
The ENMICRON survey was conducted in Guatemala during 2009 to 2010 among a sample 
of civilian, noninstitutionalized children and WCBA. Details of the ENMICRON survey, 
laboratory methods, and folate deficiency results for WCBA have been published previously 
(Rosenthal et al., 2015). The ENMICRON used a complex, multistage probability design 
with sufficient sample size and population coverage to provide representative estimates of 
RBC folate concentrations for WCBA, with national and regional representation, and 
stratified by urban and rural settings. The ENMICRON sample included 1473 nonpregnant 
WCBA who were interviewed; blood samples were obtained from 1448 of these women. 
The Guatemalan Ministry of Health requested that the study protocol be reviewed by the 
CDC Institutional Review Board in Atlanta, Georgia, United States. The protocol was 
approved in 2008 by the CDC Institutional Review Board.
 BIOCHEMICAL ANALYSES
After the interviews were completed, blood (nonfasting) was drawn for measurement of 
nutrition biomarkers. Details of the field management and processing of blood samples were 
reported earlier (Rosenthal et al., 2015). In short, blood samples were taken by venipuncture 
into tubes containing EDTA, and processed to measure RBC and plasma folate 
concentrations as described by O’Broin at the Centers for Disease Control and Prevention in 
Atlanta, Georgia, United States (O’Broin et al., 1997).
Consistent with previous analyses (Pfeiffer et al., 2011; Crider et al., 2014; Tinker et al., 
2015), we converted the folate insufficiency cutoff point (906 nmol/L) to adjust for 
differences in microbiologic assays by using the following equation:
(Pfeiffer et al., 2011; Tinker et al., 2015).
As such, <906 nmol/L (Daly microbiologic assay folate insufficiency cutoff) (Daly et al., 
1995) = <748 nmol/L (CDC microbiologic assay folate insufficiency cutoff), as established 
previously (Pfeiffer et al., 2011; Crider et al., 2014; Tinker et al., 2015).
 ANALYTICAL AND STATISTICAL METHODS
We described the variation in the prevalence estimates of RBC folate insufficiency using 
prevalence risk ratios (PRRs) for area type (urban or rural), age, ethnicity, level of education, 
wealth index, and region. We calculated point estimates and 95% confidence intervals (CIs) 
using average marginal predictions (Santos et al., 2008; Bieler et al., 2010). We performed a 
multivariable logistic regression analysis to determine independent predictors of folate 
insufficiency and to determine the adjusted folate insufficiency prevalence (i.e., predictive 
margins). We used geometric means for RBC folate because the distribution of RBC folate 
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concentrations was skewed; we adjusted mean differences for sociodemographic and other 
variables using multiple linear regression models (Proc Regress SUDAAN) (SUDDAN 
statistical software, 2012). In all analyses, we used sample weights to reflect the complex 
sample survey design and Taylor series approximation to obtain the standard errors of the 
measurements (Walter, 2007).
We modeled NTD prevalences within subpopulations (e.g., urban, rural) based on RBC 
concentration data from the ENMICRON survey. We used Bayesian methods to account for 
both the uncertainty about the true values of the RBC concentrations and the uncertainty in 
predicting NTD prevalences using RBC concentrations, as follows:
To begin, for each subpopulation we generated a hypothetical population of 100,000 women, 
each having a value for RBC concentration derived by taking a random sample from a log 
normal distribution of RBC concentrations with mean and variance for that subpopulation 
calculated from the ENMICRON survey (Table 2). For each of these 100,000 hypothetical 
women, we generated 10,000 pairs of NTD risk parameters based on a published model that 
was created to predict NTD prevalences using RBC concentrations (Crider et al., 2014). 
Specifically, we obtained each pair of NTD risk parameters by taking a random sample from 
among the final set of 20,000 posterior samples that constituted the estimated posterior 
distribution of the published model.
Using the RBC concentration and a given pair of NTD risk parameters, we could calculate a 
probability value for NTD risk. If that value was greater than a random number drawn from 
a uniform distribution between zero and one, then we counted it as an NTD case. By 
repeating this algorithm for 10,000 pairs of NTD risk parameters, we generated the number 
of NTD cases out of 10,000 for a hypothetical woman with a fixed RBC concentration. We 
then repeated this process for each of the 100,000 hypothetical women. Finally, we used the 
resulting distribution of 100,000 NTD prevalence estimates to determine the median and the 
95% uncertainty interval (defined by using the 2.5th and 97.5th percentiles).
We estimated differences in the NTD prevalence between two subpopulations (e.g., urban 
vs. rural) by calculating the difference in the NTD prevalence estimates for each of the 
100,000 hypothetical women generated for each subpopulation. We summarized the 
uncertainty in these difference estimates by using a 95% uncertainty interval bounded by the 
2.5th and 97.5th percentiles of the 100,000 difference estimates. If this 95% uncertainty 
interval for the NTD prevalence difference between the two subpopulations excluded the 
value zero, then we termed the prevalence in the subpopulation with the higher median NTD 
prevalence to “likely be greater” than that in the other subpopulation. Differences in 
estimated prevalences meeting this criteria are noted in Table 2.
 Results
 NATIONAL AND REGIONAL PREVALENCE OF RBC FOLATE INSUFFICIENCY
The national prevalence of RBC folate insufficiency was 47.2% (95% CI, 43.3–51.1) (Table 
1). The prevalence of RBC folate insufficiency varied by region and ranged from a low of 
18.8% (95% CI, 11.7–28.9) in the Metropolitana region to a high of 80.9% (95% CI, 62.7–
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91.4) in the Norte region. When compared with the Metropolitana region, all regions, with 
the exception of the Nor-Occidente, showed significantly higher adjusted PRRs for folate 
insufficiency, ranging from a low of 1.6 (95% CI, 1.0–2.5) in the Petén to 2.8 (95% CI, 1.9–
4.1) in the Norte.
 PREVALENCE OF FOLATE INSUFFICIENCY BY POPULATION CHARACTERISTICS
We found significantly higher folate insufficiency prevalence in rural areas than in urban 
areas (59.8% vs. 33.8%) (Table 1). The differences in prevalence between women in rural 
and urban areas remained significant after adjusting for other covariates (adjusted PRR 1.3 
[95% CI, 1.1–1.6]). The prevalence of RBC folate insufficiency was higher among 
indigenous women than among nonindigenous women (56.0% vs. 41.7%), but the difference 
was not significant after adjusting for other covariates.
Women with higher educational levels were more likely to have lower folate insufficiency 
prevalences (Table 1), but only in the unadjusted models. We observed significant 
differences in folate insufficiency prevalences at different wealth indices. At the low and 
middle wealth indices, women were more likely to show higher folate insufficiency 
prevalence (68.4% and 49.1%, respectively) (adjusted PRRs, 1.9 [95% CI, 1.4–2.5] and 1.5 
[95% CI, 1.1–1.9]) compared with women in the high wealth index (26.8%) (Table 1).
 PREVALENCE OF FOLATE INSUFFICIENCY BY REGION STRATIFIED BY AREA, WEALTH 
INDEX, AND ETHNICITY
Because both area type (urban or rural) and wealth index likely affected access to fortified 
staples in each region, we assessed the independent effects of area and wealth index in each 
region (Supplementary Table S1, which is available online). Across regions, there was a 
consistently higher prevalence of folate insufficiency among women in rural areas than those 
in urban areas. Prevalence of folate insufficiency in rural areas was lowest in the 
Metropolitana region (26.6%), whereas the highest prevalences were found to be in the 
Norte (88.8%) and Central (70.9%) regions. Differences in folate insufficiency prevalence 
between rural and urban areas only reached statistical significance in the Norte and Central 
regions (adjusted PRR = 1.2 [95% CI, 1.04–1.4] and 1.5 [95% CI, 1.1–2.1], respectively).
Supplementary Table S1 also shows that the prevalence of folate insufficiency in each region 
varied by wealth index. The prevalence of folate insufficiency among those in the low wealth 
index was lowest in the Metropolitana region (22.5%); this region’s prevalence was much 
lower than that of any other region (55.2–94.6%). Only the Metropolitana and Petén regions 
did not show significant differences in the prevalence of folate insufficiency by wealth index.
The prevalence of folate insufficiency was higher among indigenous populations in all 
regions, with the exception of the Metropolitana region; however, statistically significant 
differences were demonstrated only in Norte, Nor-Oriente, and Sur-Oriente regions (Supp. 
Table S2).
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 GEOMETRIC MEANS AND PERCENTILE DISTRIBUTION OF RBC FOLATE 
CONCENTRATIONS
Table 2 shows that the national median (50th percentile) RBC folate concentration among 
women 15 to 49 years of age was 766 nmol/L which is above the cutoff point of 748 nmol/L 
for folate insufficiency. However, the median RBC folate concentrations for women who 
resided in rural settings, were indigenous, had no or only primary education, and were in the 
lowest wealth index were below the folate insufficiency cutoff point. Similarly, five of the 
eight regions showed median RBC folate concentrations below the folate insufficiency 
cutoff point and in the Norte region, 75% of women were folate insufficient.
 PREDICTED NTD RISK BASED ON RBC FOLATE CONCENTRATION PERCENTILES
Based on the RBC folate concentration distributions, the estimated NTD risk for the overall 
population was 14 NTDs per 10,000 births (95% uncertainty interval [UI], 11–19). The NTD 
risk was higher among rural women (19; 95% UI, 14–23) than among urban women (11; 
95% UI, 8–13) (Tables 2, 3; Fig. 1). Furthermore, when assessing NTD risk by region, 
regions with a high number of low income and indigenous women were at the highest NTD 
risk (e.g., Norte region: 26; 95% UI, 19–35). NTD risk was much lower in the Metropolitan 
region (11; 95% UI, 8–14), with other regions at intermediate risk (Tables 2, 3; Supp. Fig. 
S1). The high NTD risk were driven by the very high risks among those at the lower end of 
the distributions (5th–25th) (Fig. 1; Supp. Fig. S1; Table 3).
 Discussion
This is the first study that has applied the new WHO guidelines to population-based data to 
assess folate insufficiency prevalence and predict NTD risk outside the United States and in 
a low or middle income country. Our study indicates that during 2009 to 2010, folate 
insufficiency was a countrywide public health problem in Guatemala, with an overall 
prevalence of 47.2%. The study revealed major regional disparities, with seven of eight 
regions having high prevalence of folate insufficiency ranging from 46.8 to 80.9%. The 
results clearly show that folate insufficiency is widespread in rural, lower socioeconomic 
status, and indigenous populations. The Metropolitana region had the lowest folate 
insufficiency prevalence (18.8%), similar to the overall level in the United States of 22.8% 
(Tinker et al., 2015), indicating the success of folic acid fortification efforts in this region, 
that is, the population likely has access to fortified wheat flour.
In Guatemala, we found that the most vulnerable subpopulations were at highest risk of 
folate insufficiency. A woman’s area of residence (i.e., urban or rural), wealth index, and 
ethnicity were among the strongest predictors of whether she had folate insufficiency. These 
results were consistent with those reported by Imhoff-Kunsch et al. (2007) in which the 
effect of wheat flour fortification on folate status in Guatemala was examined by urbanicity, 
ethnicity, and socioeconomic status. The authors found that folic acid fortification 
contributed to the estimated average requirement for women living in rural and urban areas 
by 15% and 78%, respectively, and for the indigenous and nonindigenous populations by 
10% and 57%, respectively. These results, as well as ours, suggest that vulnerable 
populations have limited access to fortified staples, likely due to lack of availability (e.g., in 
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rural areas) and/or lack of means to purchase fortified staples (e.g., those in poverty or 
extreme poverty) (Popkin and Haines, 1981; Imhoff-Kunsch et al., 2007; Frohlic and Potvin, 
2008; Iannotti et al., 2012).
In addition, we found that ethnicity was associated strongly with folate insufficiency in 
Guatemala. Two main ethnic groups account for most of the population: the indigenous 
people, who are descendants of Mayan and other indigenous groups and who maintain their 
own cultural identity and language, and Ladinos, who are of mixed indigenous and 
European origins and who speak Spanish. In Guatemala, ethnicity is closely tied to 
economic status; the indigenous population is, in general, found in the lowest wealth levels, 
while Ladinos are members of all economic classes (World Bank, 2009). Ethnic identities in 
Guatemala also may be associated with health beliefs and dietary practices that can 
influence whether intake of fortified staples is sought or accepted (Cosminsky, 1987; 
Scrimshaw and Hurtado, 1987; Leslie, 1991). Indigenous populations have a corn-based diet 
(tortillas), and because they grow their own corn or buy corn to process locally into corn 
masa flour, they are less likely to purchase fortified products. Furthermore, because women 
typically make the food and nutrition decisions for the household (Cosminsky, 1987), 
women’s acceptance of fortified foods would affect whether or not these foods are 
consumed. To our knowledge, no studies have researched these issues in Guatemala.
Comparisons of NTD predicted risk in the present study with other observed NTD 
prevalence at prefortification and postfortification periods are important because they can 
provide guidance on how populations or subgroups of populations are standing in regard to 
NTD risk. Within-country comparisons showed that our postfortification NTD predicted risk 
results indicated a national NTD predicted risk of 14 (95% UI, 11–19) per 10,000 live births 
compared to prefortification NTD prevalence of 23 per 10,000 (Chua Lopez, 2006; Acevedo 
et al., 2004). However, our study results showed higher NTD prevalence risk than 
prefortification NTD prevalence in the Norte region (26 per 10,000 vs. 23 per 10,000); Nor-
Oriente (17 vs. 14 per 10,000); Sur-Oriente (16 vs. 6 per 10,000); and lower risk in the 
Metropolitana region (11 vs. 16 per 10,000); Central (17 vs. 19 per 10,000); Sur-Occidente 
(17 vs. 28 per 10,000); Nor-Occidente (11 vs. 27 per 10,000); and Petén (13 vs. 14 per 
10,000) regions (Salguero Garcia et al., 2009; Chua Lopez, 2006). It is clear that the 
population sub-groups that bear the highest burden are among the rural, indigenous, and 
poorest groups.
In countries that have implemented successful fortification programs (e.g., Chile, Costa 
Rica, and the United States), the NTD prevalence ranges from 5.4 to 8.3 per 10,000 live 
births (Hertrampf and Cortes, 2008; Arguello and Umaña, 2011; Williams et al., 2015). Our 
results suggest that, although mandatory fortification has been successful in high- and 
middle-income countries where a very large proportion of the population has access to 
industrially produced fortified products, mandatory fortification has been only partially 
successful in low- and middle-income countries where vulnerable populations may have 
limited access to fortified foods. In such countries there is a need for studies of food 
preferences and availability (or daily consumption data) among vulnerable populations. 
These data would provide information to help identify population at risk and appropriate 
foods to consider for fortification.
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In accordance with the WHO recommendations, we determined folate insufficiency using 
population-based RBC folate concentrations measured with the microbiologic assay 
(ENMICRON 2009–2010 for women ages 15–49 years). Because the 906 nmol/L threshold 
was derived using a different calibrator for the microbiologic assay, we adjusted the 
threshold to 748 nmol/L in accordance with previous analyses (Tinker et al., 2015). While 
this conversion is based on >2600 paired samples (r = 0.92), the uncertainly associated with 
the conversion cannot be accounted for in the analysis. Also, we were able to model NTD 
risk based on RBC folate concentrations but we were not able to model the relationship 
between folic acid intake and RBC folate concentrations because we did not collect intake 
information.
In addition, the relationship between NTD risk and RBC folate concentrations is based on a 
study of pregnant women, and we are assuming that Guatemala women will behave in a 
similar way and are not directly linked to pregnancy outcomes as reported by Daly et al., 
1995. Finally, at this time there are no population-based estimates of NTD prevalence in 
Guatemala to compare with the folate-insufficiency based NTD estimates. Predicted NTD 
risk estimates are not a substitute for actual NTD prevalence. However, there are two 
hospital-based studies that estimated NTD prevalence. Ortiz and Kestler (2006) estimated 
the prevalence to be 20 per 10,000 live births, and Salguero-García et al. (2009) estimated 
the prevalence to be 19 per 10,000 live births, estimates that are consistent with the NTD 
range predicted by the population-based RBC folate concentrations among the WCBA.
There were several strengths to our study. In particular, the ENMICRON survey is a 
nationally and regionally representative sample of the Guatemalan WCBA with low non-
response rate and extensive information on different population characteristics.
 PUBLIC HEALTH IMPLICATIONS
This is the first time the new WHO guideline has been applied outside the United States. 
This analysis shows the utility of RBC folate concentrations as part of biomarker surveys to 
assess the potential and realized impact of a folic acid fortification programs. RBC folate 
concentrations clearly show that among subpopulations that are most likely to have fortified 
staples, the prevalence of folate insufficiency is similar to countries with well-established 
fortification programs. However, folate insufficiency remains common among the poor, rural 
and indigenous subpopulations. At the time of the study, almost 50% of WCBA in 
Guatemala had blood folate concentrations that were less than the recommended WHO 
threshold for optimal NTD prevention. In particular, women in the Norte region are 
predicted to be at the greatest risk of folate sensitive NTDs, with 80.9% being folate 
insufficient.
Additional preventions efforts should target this high risk region to increase folic acid intake 
and RBC folate concentrations among WCBA. New efforts should also attempt to reach 
women with low household incomes and indigenous food consumption patterns. Finally, 
given the high prevalence of folate insufficiency among WCBA in Guatemala and the strong 
predicted risk of NTDs, future efforts should include population-based surveillance to 
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monitor trends in NTD prevalence and follow-up biomarker surveys to confirm that 
programs are reaching the overall population at risk.
 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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TABLE 1
Unadjusted and Adjusted Prevalence Risk Ratios (PRR) for Red Blood Cell (RBC) Folate Insufficiency (< 748 









RBC folate insufficiency (< 748 nmol/L)
National 1448  47.2 (43.3, 51.1)
Region
 Metropolitana 141 18.8 (11.7, 28.9) Referent       Referent
 Norte 107 80.9 (62.7, 91.4) 4.3 (2.6, 7.0)*** 2.8 (1.9, 4.1)***
 Nor-Oriente 216 52.1 (41.7, 62.3) 2.8 (1.7, 4.5)*** 1.8 (1.2, 2.7)*
 Sur-Oriente 161 51.6 (41.0, 62.1) 2.7 (1.7, 4.5)*** 1.8 (1.2, 2.7)**
 Central 219 56.8 (47.4, 65.7) 3.0 (1.9, 4.9)*** 2.2 (1.5, 3.2)***
 Sur-Occidente 431 51.3 (43.7, 58.9) 2.7 (1.7, 4.4)*** 1.9 (1.3, 2.8)***
 Nor-Occidente 101 46.8 (33.3, 60.8) 2.5 (1.4, 4.3)*** 1.4 (0.9, 2.4)
 Petén   72 47.6 (35.0, 60.6) 2.5 (1.5, 4.3)*** 1.6 (1.0, 2.5)*
Area
 Rural 773 59.8 (53.9, 65.4) 1.8 (1.5, 2.1)*** 1.3 (1.1, 1.5)*
 Urban 675 33.8 (28.9, 39.0) Referent       Referent
Ethnicity
 Indigenous 559 56.0 (49.3, 62.6) 1.3 (1.1, 1.6)*** 1.0 (0.9, 1.2)
 Non-Indigenous 889 41.7 (37.3, 46.3) Referent       Referent
Age (yr)
 15 – 19 233 48.4 (40.8, 56.0) 1.0 (0.9, 1.3)      1.2 (1.0, 1.4)
 20 –34 525 48.0 (42.3, 53.9) 1.0 (0.9, 1.2)      1.1 (0.9, 1.3)
 35 – 49 690 46.0 (40.8, 51.3) Referent       Referent
Education (yr)
 None 314 59.7 (50.8, 67.9) 1.8 (1.4, 2.3)*** 1.2 (0.9, 1.5)
 Primary 715 52.0 (47.0, 56.9) 1.6 (1.3, 1.9)*** 1.1 (1.0, 1.4)
 Secondary or higher 419 32.4 (27.3, 38.8) Referent       Referent
Wealth index (terciles)
 Low 478 68.4 (61.6, 74.4) 2.6 (2.0, 3.2)*** 1.9 (1.4, 2.5)***
 Middle 538 49.1 (43.8, 54.4) 1.8 (1.4, 2.3)*** 1.5 (1.1, 1.9)**
 High 432 26.8 (21.3, 33.2) Referent       Referent
ENMICRON, Guatemala Encuesta Nacional de Micronutrientes.
a
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